KIDS Valuation

OrthoPediatrics Corp

Add to Watchlist

Advanced Chart

22.750

-0.01(-0.044%)1D

Overview
Forecast
Valuation
Earnings

KIDS Relative Valuation

KIDS's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, KIDS is overvalued; if below, it's undervalued.

Historical Valuation

OrthoPediatrics Corp (KIDS) is now in the Undervalued zone, suggesting that its current forward PS ratio of 2.27 is considered Undervalued compared with the five-year average of -46.75. The fair price of OrthoPediatrics Corp (KIDS) is between 41.95 to 93.47 according to relative valuation methord. Compared to the current price of 22.75 USD , OrthoPediatrics Corp is Undervalued By 45.77%.

Relative Value

Fair Zone

41.95-93.47

Current Price：22.75

45.77%

Undervalued

Trailing

Forward

P/E

EV/EBITDA

EV/EBIT

P/S

P/OCF

P/FCF

Trailing

Forward

1.63

P/B

Median3y

2.21

Median5y

3.17

-6.48

FCF Yield

Median3y

-5.38

Median5y

-4.25

Competitors Valuation Multiple

The average P/S ratio for KIDS's competitors is 6.38, providing a benchmark for relative valuation. OrthoPediatrics Corp Corp (KIDS) exhibits a P/S ratio of 2.27, which is -64.50% above the industry average. Given its robust revenue growth of 17.29%, this premium appears unsustainable.

P/S

P/E

EV/EBITDA

EV/EBIT

P/S

Revenue Growth

Market Cap